Navigation Links
Michaelis-Menten kinetics

Michaelis-Menten kinetics describe the rate of enzyme mediated reactions for many enzymes. It is named for Leonor Michaelis and Maud Menten. These kinetics are valid only when the concentration of substrate is higher than the concentration of enzyme, and in the particular case of steady-state, where the concentration of the complex enzyme-substrate is constant.

To determine the maximum rate of an enzyme mediated reaction, the substrate concentration ([S]) is increased until a constant rate of product formation is achieved. This is the maximum velocity (Vmax) of the enzyme. In this state, enzyme active sites are saturated with substrate. Note that at the maximum velocity, the factors that effect the rate of enzyme mediated reactions (ie. pH, temperature, etc) are at optimal values.

Diagram of reaction speed and Michaelis-Menten constant.

The speed V means the number of reactions per second that are catalyzed by an enzyme. With increasing substrate concentration [S], the enzyme is asymptotically approaching its maximum speed Vmax, but never actually reaching it. Because of that, no [S] for Vmax can be given. Instead, the characteristic value for the enzyme is defined by the substrate concentration at its half-maximum speed (Vmax/2). This KM value is also called Michaelis-Menten constant.


Michaelis constant

Since the substrate concentration at Vmax cannot be measured exactly, enzymes must be characterized by the substrate concentration at which the rate of reaction is half its maximum. This substrate concentration is called the Michaelis-Menten constant (KM) a.k.a. Michaelis constant. This represents (for enzyme reactions exhibiting simple Michaelis-Menten kinetics) the dissociation constant (affinity for substrate) of the enzyme-substrate (ES) complex. Low values indicate that the ES complex is held together very tightly and rarely dissociates without the substrate first reacting to form product.


The derivation of "Michaelis-Menten" was actually described by Briggs and Haldane. It is obtained as follows:

The enzymatic reaction is supposed to be irreversible, and the product does not rebind the enzyme.

Because we follow the steady-state approximation:

Let's define:




The velocity of the reaction is:


The totale concentration of enzyme is:

[E0] = [E] + [ES]


[ES] = [E0] - [E] (3)

Substituting (1) in (3):


Substituting (4) in (2) and multiplying numerator and denominator by [S]:

  • E0 is the total or starting amount of enzyme. It is not practical to measure the amount of the enzyme substrate complex during the reaction, so the reaction must be written in terms of the total (starting) amount of enzyme, a known quantity.
  • d[P]/dt a.k.a. V0 a.k.a. reaction velocity a.k.a. reaction rate is the rate of production of the product. Note that the term reaction velocity is misleading and reaction rate is preferred.
  • k2[E0] a.k.a. Vmax is the maximum velocity or maximum rate. k2 is often called kcat.

Notice that if [S] is large compared to Km, [S]/(Km + [S]) approaches 1. Therefore, the rate of product formation is equal to k2[E0] in this case.

When [S] equals Km, [S]/(Km + [S]) equals 0.5. In this case, the rate of product formation is half of the maximum rate (1/2 Vmax). By plotting V0 against [S], one can easily determine Vmax and Km. Note that this requires a series of experiments at constant E0 and different substrate concentration [S].


The relationship between substrate concentration and enzyme concentration was proposed in 1913 by Leonor Michaelis and Maud Menten, following earlier work by Archibald Vivian Hill.

Leonor Michaelis, Maud Menten (1913). Die Kinetik der Intertinwerkung, Biochem. Z. 49:333-369.

The current derivation has been proposed by Briggs and Haldane

G. E. Briggs and J. B. S. Haldane (1925) A note on the kinetics of enzyme action, Biochem. J., 19, 339-339.



(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
(Date:10/27/2015)... SAN JOSE, Calif. , Oct. 27, 2015 /PRNewswire/ ... human interface solutions, today announced that Google has adopted ... family of touch controller solutions to power its newest ... Nexus 6P by Huawei. --> ... ecosystem partners like Google to provide strategic collaboration in ...
Breaking Biology News(10 mins):
Other biology definition